Supernus Pharmaceuticals Inc (SUPN)
Total Costs & Expenses
$942.25M
TTM · Period ending: · USD
SUPN Total Costs & Expenses
Latest reported$942.25Mperiod ending
Latest reported$942.25Mperiod ending
SUPN TTM Total Costs & Expenses ($38.56M → $942.25M)
TTM Total Costs & Expenses
High-resolution chart · PNG
SUPN total costs & expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 942,251,000 | |
| 818,542,000 | |
| 763,476,000 | |
| 718,480,000 | |
| 600,990,000 | |
| 593,434,000 | |
| 580,151,000 | |
| 592,707,000 | |
| 603,605,000 | |
| 610,999,000 | |
| 612,790,000 | |
| 580,474,000 | |
| 613,608,000 | |
| 619,163,000 | |
| 621,114,000 | |
| 641,072,000 | |
| 578,056,000 | |
| 526,567,000 | |
| 493,746,000 | |
| 441,353,000 | |
| 424,488,000 | |
| 398,453,000 | |
| 346,699,000 | |
| 305,770,000 | |
| 269,186,000 | |
| 250,102,000 | |
| 244,184,000 | |
| 260,633,000 | |
| 263,743,000 | |
| 265,464,000 | |
| 264,453,000 | |
| 242,465,000 | |
| 235,000,000 | |
| 220,944,000 | |
| 202,697,000 | |
| 194,684,000 | |
| 173,599,000 | |
| 163,818,000 | |
| 160,787,000 | |
| 150,515,000 | |
| 147,821,000 | |
| 139,816,000 | |
| 126,762,000 | |
| 117,028,000 | |
| 106,072,000 | |
| 100,015,000 | |
| 97,815,000 | |
| 93,434,000 | |
| 88,545,000 | |
| 78,386,000 | |
| 73,938,000 | |
| 66,081,000 | |
| 60,030,000 | |
| 53,618,000 | |
| 43,649,000 | |
| 40,100,000 | |
| 37,645,000 | |
| 37,443,000 | |
| 38,555,000 | |
| 39,030,530 | |
| 37,706,873 |